Evidence map›Paper›PMID 39790189›Full record

ArticleCardiovascular diagnosis and therapy2024

Reporting quality of animal research in journals that published the ARRIVE 1.0 or ARRIVE 2.0 guidelines: a cross-sectional analysis of 943 studies.

Yao Lin, Fanghui Yang, Binghan Shang, John E Speich, Yu-Jui Yvonne Wan, Hiroki Hashida, Tobias Braun, Ali Sadoughi, Thomas Puehler, Tom F Lue and 1 more

Abstract read
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yao Lin *Editorial Office, AME Publishing Company, Hong Kong, China.
Fanghui Yang *Editorial Office, AME Publishing Company, Hong Kong, China.
Binghan ShangEditorial Office, AME Publishing Company, Hong Kong, China.
John E SpeichDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University College of Engineering, Richmond, Virginia, USA.
Yu-Jui Yvonne WanDepartment of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA.
Hiroki HashidaDepartment of Surgery, Hanwa Memorial Hospital, Osaka, Japan.
Tobias BraunDepartment of Neurology, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.
Ali SadoughiDepartment of Medicine, Division of Pulmonology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Thomas PuehlerDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Tom F LueDepartment of Urology, School of Medicine, University of California, San Francisco, CA, USA.
Kaiping ZhangEditorial Office, AME Publishing Company, Hong Kong, China.ORCID https://orcid.org/0000-0002-7645-2631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The adherence to the Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines across the journals that initially published the guidelines and if adherence has improved since the guidelines update, remains unknown. We aimed to quantify the level of adherence and analyze factors that might influence reporting quality among these journals. Methods: This cross-sectional study retrospectively analyzed interventional animal experiments published in journals that released ARRIVE 1.0 and 2.0 guidelines in three periods: 5 years before (Pre-ARRIVE 1.0) and after (Post-ARRIVE 1.0) the publication of ARRIVE 1.0, and 1 year after the publication of ARRIVE 2.0 (Post-ARRIVE 2.0). Reviewers independently assessed adherence to the ARRIVE guidelines. Basic information and potential influencing factors were extracted. Adherence data were presented as frequency (percentages). Statistical factors influencing reporting quality were evaluated using the Chi-square test or Fisher's exact test. Results: 215, 330, and 398 experiments were included during Pre-ARRIVE 1.0, Post-ARRIVE 1.0 and Post-ARRIVE 2.0 periods, respectively. None of the included 943 studies reported all 38 subitems, showing only 0%, 0%, and 0.25% studies had an "excellent" reporting quality across the three periods. The overall reporting quality was significantly improved among Pre-ARRIVE 1.0, Post-ARRIVE 1.0 and Post-ARRIVE 2.0 (P<0.001). The rate of studies with "average" reporting quality increased sequentially from 53.95% to 73.94% and then to 90.20%, and those with "poor" reporting quality decreased sequentially from 46.05% to 26.06% and then to 9.55% across the three periods. Specifically, 15 out of 38 (39.5%) subitems and 11 out of 27 (40.7%) similar and comparable subitems demonstrated a significant higher percentage of "fully reported" in Post-ARRIVE 1.0 compared to Pre-ARRIVE 1.0 and in Post-ARRIVE 2.0 compared to Post-ARRIVE 1.0, respectively (P<0.05). Country and journal indexing did not significantly affect reporting quality (both P>0.05). However, significant differences in reporting quality were found among the mandatory adherence to the ARRIVE guidelines in the author's instructions and reference to ARRIVE in the manuscript (both P<0.001). Conclusions: In the journals that initially published the ARRIVE guidelines, compliance with the guidelines still has room for improvement, though it has increased sequentially since introducing the guidelines. Implementing mandatory adherence requirements in the author's instructions and explicitly recognizing adherence to ARRIVE in articles could enhance the reporting quality of interventional animal experiments.

Indexed as

adherenceanimal experimentsAnimals in Research: Reporting In Vivo Experiments guidelines (ARRIVE guidelines)in vivo studyreporting quality

Identifiers

PMID39790189
PMCPMC11707473

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.